Rafael Amado - Mar 12, 2025 Form 4 Insider Report for Zai Lab Ltd (ZLAB)

Role
President, Head of Global Oncology Research and Development
Signature
/s/ Bruce Blefeld, Attorney-in-Fact
Stock symbol
ZLAB
Transactions as of
Mar 12, 2025
Transactions value $
$0
Form type
4
Date filed
3/14/2025, 05:14 PM
Previous filing
Jan 8, 2025
Next filing
Mar 19, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZLAB Stock Options (Right to Buy) Award $0 +65.5K $0.00 65.5K Mar 12, 2025 American Depositary Shares 65.5K $35.55 Direct F1, F2
transaction ZLAB Restricted Share Units Award $0 +21.3K $0.00 21.3K Mar 12, 2025 American Depositary Shares 21.3K Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
F2 The option vests in equal annual installments over four years beginning on 03/12/2026, the first anniversary of the date of grant, subject to continuous service.
F3 Each Restricted Share Unit ("RSU") represents a contingent right to receive one ADS.
F4 The RSUs vest in equal annual installments over four years beginning on 03/12/2026, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.

Remarks:

President, Head of Global Oncology Research and Development